🇺🇸 FDA
Pipeline program

PT150

H250195

Phase 2 small_molecule active

Quick answer

PT150 for PTSD - Post Traumatic Stress Disorder is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
PTSD - Post Traumatic Stress Disorder
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials